BENSULFOID
LOE Approachingsulfur
NDATOPICALPOWDER
Approved
Sep 1940
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
2/8 — Basic
Drug data last refreshed 3h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BENSULFOID is a topical powder formulation of elemental sulfur, an established dermatological agent with keratolytic and antimicrobial properties. It is primarily used for the treatment of scabies, seborrheic dermatitis, and other parasitic and fungal skin conditions. Sulfur works by penetrating the stratum corneum and disrupting the cellular membranes of parasites and microorganisms.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30%), indicating a mature, stable but potentially declining revenue base with limited growth opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer
Started Jan 2024
213 enrolled
Sentinel NodesBreast Cancer
Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies
Started Mar 2022
60 enrolled
Scabies
Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH
Started Dec 2017
6 enrolled
Nonalcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy
Started Feb 2012
2 enrolled
Myopathy
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.